News

A key factor in this process is the position of the Portuguese government. The Portuguese authorities expressed their “displeasure” at the possibility of Caixabank, already with a significant presence ...
NOVO BANCO S.A. (XS1053939978) - All master data, key figures and real-time diagram.
NOVO BANCO S.A. (XS1038896426) - All master data, key figures and real-time diagram.
Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes.
Ozempic has become a popular off-label tool to support weight management. Learn what experts say on Ozempic for weight loss, its safety and effectiveness.